ATE331716T1 - Nicht-nukleosidische inhibitoren der reverse transkriptase - Google Patents

Nicht-nukleosidische inhibitoren der reverse transkriptase

Info

Publication number
ATE331716T1
ATE331716T1 AT03816107T AT03816107T ATE331716T1 AT E331716 T1 ATE331716 T1 AT E331716T1 AT 03816107 T AT03816107 T AT 03816107T AT 03816107 T AT03816107 T AT 03816107T AT E331716 T1 ATE331716 T1 AT E331716T1
Authority
AT
Austria
Prior art keywords
sub
sup
alkyl
reverse transcriptase
cycloalkyl
Prior art date
Application number
AT03816107T
Other languages
English (en)
Inventor
Christiane Yoakim
Eric Malenfant
Bounkham Thavonekham
William W Ogilvie
Robert Deziel
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Application granted granted Critical
Publication of ATE331716T1 publication Critical patent/ATE331716T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
AT03816107T 2002-09-19 2003-09-15 Nicht-nukleosidische inhibitoren der reverse transkriptase ATE331716T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41178502P 2002-09-19 2002-09-19

Publications (1)

Publication Number Publication Date
ATE331716T1 true ATE331716T1 (de) 2006-07-15

Family

ID=33097881

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03816107T ATE331716T1 (de) 2002-09-19 2003-09-15 Nicht-nukleosidische inhibitoren der reverse transkriptase

Country Status (9)

Country Link
US (1) US7105510B2 (de)
EP (1) EP1554276B1 (de)
JP (1) JP4391426B2 (de)
AT (1) ATE331716T1 (de)
AU (1) AU2003303944A1 (de)
CA (1) CA2495721C (de)
DE (1) DE60306539T2 (de)
ES (1) ES2268499T3 (de)
WO (1) WO2004085437A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004054586A1 (en) * 2002-12-16 2004-07-01 Boehringer Ingelheim International Gmbh Use of a combination containing a non-nucleoside reverse transcriptase inhibitor (nnrti) with an inhibitor of cytochrome p450, such as protease inhibitors
GB0507695D0 (en) * 2005-04-15 2005-05-25 Novartis Ag Organic compounds
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
CN101801930B (zh) 2007-09-14 2013-01-30 奥梅-杨森制药有限公司 1,3-二取代的-4-苯基-1h-吡啶-2-酮
PL2200985T3 (pl) 2007-09-14 2011-12-30 Ortho Mcneil Janssen Pharmaceuticals Inc 1,3-Dipodstawione-4-(arylo-X-fenylo)-1H-pirydyn-2-ony
SI2203439T1 (sl) 2007-09-14 2011-05-31 Ortho Mcneil Janssen Pharm 1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
CN101861316B (zh) 2007-11-14 2013-08-21 奥梅-杨森制药有限公司 咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
EP2344470B1 (de) 2008-09-02 2013-11-06 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexylderivate als modulatoren von metabotropen glutamatrezeptoren
WO2010043396A1 (en) 2008-10-16 2010-04-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
JP5690277B2 (ja) 2008-11-28 2015-03-25 ジャンセン ファーマシューティカルズ， インコーポレイテッド． 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
CN102439008B (zh) 2009-05-12 2015-04-29 杨森制药有限公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途
BRPI1010831A2 (pt) 2009-05-12 2016-04-05 Addex Pharmaceuticals Sa derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
US9271967B2 (en) 2010-11-08 2016-03-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
MX386697B (es) 2014-01-21 2025-03-19 Janssen Pharmaceutica Nv Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso
ME03518B (de) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinationen mit positiven allosterischen modulatoren von metabotropem glutamatergen rezeptor vom subtyp 2 und deren verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705499A (en) 1995-10-06 1998-01-06 Boehringer Ingelheim Pharmaceuticals, Inc. 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
EP1554276A1 (de) 2005-07-20
ES2268499T3 (es) 2007-03-16
WO2004085437A1 (en) 2004-10-07
DE60306539T2 (de) 2007-07-19
JP4391426B2 (ja) 2009-12-24
EP1554276B1 (de) 2006-06-28
CA2495721A1 (en) 2004-10-07
US20040106791A1 (en) 2004-06-03
DE60306539D1 (de) 2006-08-10
US7105510B2 (en) 2006-09-12
AU2003303944A1 (en) 2004-10-18
CA2495721C (en) 2009-08-18
JP2006515312A (ja) 2006-05-25

Similar Documents

Publication Publication Date Title
ATE331716T1 (de) Nicht-nukleosidische inhibitoren der reverse transkriptase
ECSP045359A (es) Isoxazolinas 5 metiloximetil sustituidas por 3-heteroarilo utilizadas con herbicidas
BG101422A (bg) Бензоксазолни производни като бронхоразширяващи средства
DK0408382T3 (de)
JO2791B1 (en) Acid secretion inhibitor
ATE449099T1 (de) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
EA200200819A1 (ru) Кристаллическая форма ii линезолида
ATE112764T1 (de) Diphenylpiperazinderivat.
ATE386037T1 (de) Nicht-nucleosidische inhibitoren der reverse transkriptase
NO944371D0 (no) Kjemisk forbindelse med blodplateaggregeringsinhiberende virkning
EA200201255A1 (ru) Ненуклеозидные ингибиторы обратной транскриптазы
MA27077A1 (fr) Derives de 2-amino-4-heteroarylethyl thiazoline et leur utilisation comme inhibiteurs de no-synthase inductible
CY1113031T1 (el) Παραγωγα ν-αμινοϊμιδαζολιου που αναστελουν ηιv
NO20033131L (no) Anvendelse av 2-amino-4-pyridylmetyl-tiazolinderivater som inhibitorer forinduktibel NO-syntase
WO2020003272A8 (en) An improved process for the preparation of venetoclax
DK1165485T3 (da) Fremgangsmåde til fremstilling af pesticidmellemprodukter
KR890000459A (ko) 피란 화합물
EA200001036A1 (ru) Способы ингибирования mrp1
DE3750307D1 (de) Fungizide Pyridyl-cyclopropancarboxamide.
DE602005011177D1 (de) Pyridinketone mit herbizideffekt
EA200501556A1 (ru) Гетеробициклические соединения в качестве фунгицидов
ATE395063T1 (de) Pyridlsulfonamidopyrimidine zur behandlung von diabetischer nephropathie
DE60330381D1 (de) Zusammensetzung zur bekämpfung von arthropoden
EA200500138A1 (ru) Фунгицидные смеси на базе дитианона
CO5580804A2 (es) Derivados de diazepanes utiles como inhibidores de lfa

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1554276

Country of ref document: EP